Repression of cardiac phospholamban gene expression is mediated by thyroid hormone receptor-{alpha}1 and involves targeted covalent histone modifications.
Phospholamban (PLB) is a critical regulator of Ca(2+) cycling in heart muscle cells, and its gene expression is markedly down-regulated by T(3). Nonetheless, little is known about the molecular mechanisms of T(3)-dependent gene silencing in cardiac muscle, and it remains unclear whether thyroid hormone receptors (TRs) directly bind at the PLB gene in vivo and facilitate transcriptional repression. To investigate the regulatory role of TRs in PLB transcription, we used a physiological murine heart muscle cell line (HL-1) that retains cardiac electrophysiological properties, expresses both TRalpha1 and TRbeta1 subtypes, and exhibits T(3)-dependent silencing of PLB expression. By performing RNA interference assays with HL-1 cells, we found that TRalpha1, but not TRbeta1, is essential for T(3)-dependent PLB gene repression. Interestingly, a PLB reporter gene containing only the core promoter sequences -156 to +64 displayed robust T(3)-dependent silencing in HL-1 cells, thus suggesting that transcriptional repression is facilitated by TRalpha1 via the PLB core promoter, a regulatory region highly conserved in mammals. Consistent with this notion, chromatin immunoprecipitation and in vitro binding assays show that TRalpha1 directly binds at the PLB core promoter region. Furthermore, addition of T(3) triggered alterations in covalent histone modifications at the PLB promoter that are associated with gene silencing, namely a pronounced decrease in both histone H3 acetylation and histone H3 lysine 4 methylation. Taken together, our data reveal that T(3)-dependent repression of PLB in cardiac myocytes is directly facilitated by TRalpha1 and involves the hormone-dependent recruitment of histone-modifying enzymes associated with transcriptional silencing.
Belakavadi
Madesh
M
Department of Physiology and Biophysics, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854, USA.
Saunders
Jason
J
Weisleder
Noah
N
Raghava
Preethi S
PS
Fondell
Joseph D
JD
D000818:Animals; D002135:Calcium-Binding Proteins / Q000235:genetics*; D002460:Cell Line; D047369:Chromatin Immunoprecipitation; D018274:Electroporation; D015870:Gene Expression / Q000187:drug effects; D006657:Histones / Q000378:metabolism*; D015151:Immunoblotting; D051379:Mice; D018613:Microscopy, Confocal; D032383:Myocytes, Cardiac / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000235:genetics; D034622:RNA Interference; D047490:Retinoid X Receptor alpha / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases / Q000235:genetics / Q000378:metabolism; D037021:Thyroid Hormone Receptors alpha / Q000235:genetics / Q000378:metabolism*; D014284:Triiodothyronine / Q000494:pharmacology*; D000099211:Phospholamban
D002135:Calcium-Binding Proteins; D006657:Histones; D047490:Retinoid X Receptor alpha; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; D037021:Thyroid Hormone Receptors alpha; D014284:Triiodothyronine; D000099211:Phospholamban
Nature. 2007 Apr 19;446(7138):882-7
17392792
Cell. 2004 Dec 29;119(7):941-53
15620353
Trends Endocrinol Metab. 2000 Jan-Feb;11(1):6-10
10652499
J Mol Cell Cardiol. 2007 Jun;42(6):1026-35
17509612
Annu Rev Physiol. 2000;62:439-66
10845098
J Mol Cell Cardiol. 1999 Dec;31(12):2137-53
10640442
Proc Natl Acad Sci U S A. 1989 Dec;86(23):9114-8
2480596
J Physiol. 2009 Mar 15;587(Pt 6):1319-29
19171649
EMBO J. 1998 Jan 15;17(2):455-61
9430637
Cell Calcium. 2007 Dec;42(6):548-55
17412417
Mol Cell. 2003 Jan;11(1):139-50
12535528
Vitam Horm. 2004;68:93-122
15193452
Nature. 2003 Apr 17;422(6933):735-8
12700765
Genes Dev. 2000 Jan 15;14(2):121-41
10652267
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7934-9
12034878
Mol Cell Biol. 1997 May;17(5):2642-8
9111334
Mol Endocrinol. 1995 May;9(5):540-50
7565802
Circ Res. 1994 Aug;75(2):245-51
8033338
Gene. 1997 Dec 12;203(2):199-207
9426251
Mol Cell. 2005 Sep 2;19(5):631-42
16137620
Mol Endocrinol. 2000 Jul;14(7):947-55
10894146
Mol Endocrinol. 2007 Apr;21(4):865-84
17244762
Thyroid. 2000 Jan;10(1):41-52
10691312
N Engl J Med. 2001 Feb 15;344(7):501-9
11172193
J Mol Biol. 2005 Nov 4;353(4):763-71
16213525
Biochem Biophys Res Commun. 1997 Apr 28;233(3):838-43
9168944
Eur J Endocrinol. 2001 Jul;145(1):59-64
11415853
J Mol Cell Cardiol. 1994 Sep;26(9):1145-54
7815458
Physiol Rev. 2001 Jul;81(3):1097-142
11427693
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2979-84
9501201
Thyroid. 2002 Jun;12(6):453-7
12165106
EMBO J. 1999 Oct 1;18(19):5389-98
10508171
J Endocrinol. 2006 May;189(2):231-45
16648291
Biochem Biophys Res Commun. 1992 Oct 30;188(2):927-33
1445334
Thyroid. 2007 Dec;17(12):1211-23
18177256
Recent Prog Horm Res. 2004;59:31-50
14749496
Oncogene. 2001 May 28;20(24):3014-20
11420716
Circ Res. 1991 Aug;69(2):266-76
1830516
Mol Endocrinol. 2004 Apr;18(4):863-73
14715929
Proc Natl Acad Sci U S A. 1989 Apr;86(8):2966-70
2523077
Endocr Rev. 1987 Aug;8(3):288-308
3308445
Endocrinology. 2001 Feb;142(2):544-50
11159823
J Mol Endocrinol. 2004 Aug;33(1):21-33
15291740
J Biol Chem. 1989 Sep 5;264(25):14840-7
2768243
J Mol Cell Cardiol. 1999 Mar;31(3):679-92
10198197
J Biol Chem. 2004 Sep 10;279(37):38797-802
15231818
Front Biosci. 2006 Jan 01;11:344-55
16146736
Nature. 2007 May 24;447(7143):407-12
17522673
Methods Mol Biol. 2002;202:195-214
12094605
Endocr Rev. 2005 Aug;26(5):704-28
15632316